The Role of Brain-Derived Neurotrophic Factor as an Essential Mediator in Neuronal Functions and the Therapeutic Potential of Its Mimetics for Neuroprotection in Neurologic and Psychiatric Disorders
Top Cited Papers
Open Access
Abstract
Among neurotrophins, including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4/5), BDNF has been extensively studied for its physiological role in cell survival and synaptic regulation in the central nervous system’s (CNS’s) neurons. BDNF binds to TrkB (a tyrosine kinase) with high affinity, and the resulting downstream intracellular signaling cascades play crucial roles in determining cell fate, including neuronal differentiation and maturation of the CNS neurons. It has been well demonstrated that the downregulation/dysregulation of the BDNF/TrkB system is implicated in the pathogenesis of neurologic and psychiatric disorders, such as Alzheimer’s disease (AD) and depression. Interestingly, the effects of BDNF mimetic compounds including flavonoids, small molecules which can activate TrkB-mediated signaling, have been extensively investigated as potential therapeutic strategies for brain diseases, given that p75NTR, a common neurotrophin receptor, also contributes to cell death under a variety of pathological conditions such as neurodegeneration. Since the downregulation of the BDNF/TrkB system is associated with the pathophysiology of neurodegenerative diseases and psychiatric disorders, understanding how alterations in the BDNF/TrkB system contribute to disease progression could provide valuable insight for the prevention of these brain diseases. The present review shows recent advances in the molecular mechanisms underlying the BDNF/TrkB system in neuronal survival and plasticity, providing critical insights into the potential therapeutic impact of BDNF mimetics in the pathophysiology of brain diseases.Keywords
All Related Versions
Funding Information
- Japan Society for the Promotion of Science (24K09645, 35-18, 23K07772)
- Takeda Science Foundation (24K09645, 35-18, 23K07772)
- Kawano Masanori Memorial Public Interest Incorporated Foundation (24K09645, 35-18, 23K07772)
- Japan Society for the Promotion of Science (24K09645, 35-18, 23K07772)
This publication has 135 references indexed in Scilit:
- Normal huntingtin function: an alternative approach to Huntington's diseaseNature Reviews Neuroscience, 2005
- ProBDNF Induces Neuronal Apoptosis via Activation of a Receptor Complex of p75NTRand SortilinThe Journal of Neuroscience, 2005
- Cognitive functions in depressive disorders: evidence from a population-based studyPsychological Medicine, 2004
- Trk Receptors: Roles in Neuronal Signal TransductionAnnual Review of Biochemistry, 2003
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor AgonistsScience, 2002
- Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathwayCurrent Opinion in Neurobiology, 2001
- BDNF controls dopamine D3 receptor expression and triggers behavioural sensitizationNature, 2001
- Delivery of Neurotrophic Factors to the Central Nervous SystemClinical Pharmacokinetics, 2001
- TrkB Signaling Is Required for Postnatal Survival of CNS Neurons and Protects Hippocampal and Motor Neurons from Axotomy-Induced Cell DeathJournal of Neuroscience, 1997
- BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigraNature, 1991